- Home
- RFAI vs PBYI Comparison
RFAI vs PBYI Comparison
Compare RFAI & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFAI
- PBYI
- Stock Information
- Founded
- RFAI 2024
- PBYI 2010
- Country
- RFAI Singapore
- PBYI United States
- Employees
- RFAI N/A
- PBYI N/A
- Industry
- RFAI
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- RFAI
- PBYI Health Care
- Exchange
- RFAI NYSE
- PBYI Nasdaq
- Market Cap
- RFAI 156.3M
- PBYI 138.4M
- IPO Year
- RFAI 2024
- PBYI N/A
- Fundamental
- Price
- RFAI N/A
- PBYI $2.86
- Analyst Decision
- RFAI
- PBYI Strong Buy
- Analyst Count
- RFAI 0
- PBYI 1
- Target Price
- RFAI N/A
- PBYI $7.00
- AVG Volume (30 Days)
- RFAI 8.3K
- PBYI 334.3K
- Earning Date
- RFAI 01-01-0001
- PBYI 05-01-2025
- Dividend Yield
- RFAI N/A
- PBYI N/A
- EPS Growth
- RFAI N/A
- PBYI 37.78
- EPS
- RFAI N/A
- PBYI 0.62
- Revenue
- RFAI N/A
- PBYI $230,468,000.00
- Revenue This Year
- RFAI N/A
- PBYI N/A
- Revenue Next Year
- RFAI N/A
- PBYI N/A
- P/E Ratio
- RFAI $45.33
- PBYI $4.61
- Revenue Growth
- RFAI N/A
- PBYI N/A
- 52 Week Low
- RFAI $10.00
- PBYI $2.23
- 52 Week High
- RFAI $10.43
- PBYI $5.34
- Technical
- Relative Strength Index (RSI)
- RFAI N/A
- PBYI 42.27
- Support Level
- RFAI N/A
- PBYI $2.83
- Resistance Level
- RFAI N/A
- PBYI $2.99
- Average True Range (ATR)
- RFAI 0.00
- PBYI 0.17
- MACD
- RFAI 0.00
- PBYI -0.01
- Stochastic Oscillator
- RFAI 0.00
- PBYI 50.00
About RFAI RF ACQUISITION CORP II
RF Acquisition Corp II is a blank check company.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.